TWiV 1022: Clinical update with Dr. Daniel Griffin - podcast episode cover

TWiV 1022: Clinical update with Dr. Daniel Griffin

Jul 08, 202340 minEp. 1022
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

In his weekly clinical update, Dr. Griffin discusses autochthonous leprosy in the United States, a systematic review to identify novel clinical characteristics of Mpox virus infection and therapeutic and preventive strategies to combat the virus, two-year duration of immunity of inactivated poliovirus vaccine, evaluation of novel oral polio vaccine type 2 SIA impact in a large outbreak of circulating vaccine-derived poliovirus in Nigeria, performance of rapid antigen tests to detect symptomatic and asymptomatic SARS-CoV-2 Infection, effectiveness of the COVID-19 bivalent vaccine, oral Nirmatrelvir and Ritonavir for COVID-19 in vaccinated, non-hospitalized adults ages 18-50 years, genome-wide association study of long COVID, vaccination ameliorates cellular inflammatory responses in SARS-CoV-2 breakthrough infections, and high incidence of autonomic dysfunction and postural orthostatic tachycardia syndrome in patients with long-COVID.

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode
  • Autochthonous leprosy in the United States (NEJM)
  • Systematic review to identify novel clinical characteristics of Monkeypox (Archives of Virology)
  • Two-year duration of immunity of inactivated poliovirus vaccine (JID)
  • Evaluation of novel oral polio vaccine type 2 SIA impact in a outbreak of vaccine-derived poliovirus in Nigeria (IDSA)
  • Performance of rapid antigen tests to detect symptomatic and asymptomatic SARS-CoV-2 (AIM)
  • Effectiveness of the COVID-19 bivalent vaccine (OFID)
  • Oral Nirmatrelvir and Ritonavir for COVID-19 in vaccinated, non-hospitalized adults (CID)
  • Genome-wide association study of long COVID (medRxiv)
  • Vaccination ameliorates cellular inflammatory responses in SARS-CoV-2 breakthrough infections (JID)
  • High incidence of autonomic dysfunction and postural orthostatic tachycardia syndrome in patients with long-COVID (AJM)
  • Contribute to our FIMRC fundraiser at PWB
  • Letters read on TWiV 1022
  • Dr. Griffin's COVID treatment summary (pdf)
  • Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to daniel@microbe.tv

For the best experience, listen in Metacast app for iOS or Android